neuroblastoma

From Aaushi
Jump to navigation Jump to search

Epidemiology

Pathology

Microscopic pathology

Electron microscopy:

Immunophenotype

Genetics

* impaired telomere maintenance, no NRAS or Tp53 gene mutation associated with 100% survival[3]

Laboratory

Staging

Complications

Differential diagnosis

Management

More general terms

More specific terms

Additional terms

References

  1. 1.0 1.1 Journal Watch 22(10):80, 2002
    Wood WG et al, N Engl J Med 346:1041, 2002
    Schilling FH et al, N Engl J Med 346:1047, 2002
    Cuningham G, N Engl J Med 346:1084, 2002
  2. Brodeur. Nature Reviews Cancer 3:203-216, 2003
  3. 3.0 3.1 3.2 3.3 Ackermann S, Cartolano M, Hero B et al. A mechanistic classification of clinical phenotypes in neuroblastoma. Science. 2018 Dec 7;362(6419):1165-1170. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/30523111 <Internet> http://science.sciencemag.org/content/362/6419/1165
  4. 4.0 4.1 http://www.pathologyoutlines.com/adrenal.html
  5. ARUP Consult: Neuroblastoma The Physician's Guide to Laboratory Test Selection & Interpretation https://www.arupconsult.com/content/neuroblastoma
  6. 6.0 6.1 Forster V Platinum Chemotherapy Appears to Cause Clonal Expansion Leading to Myeloid Neoplasms in Children With Neuroblastoma. Cancer Therapy Advisor. July 16, 2021 https://www.cancertherapyadvisor.com/home/cancer-topics/pediatric-cancer/neuroblastoma-platinum-chemotherapy-cause-clonal-expansion-treatment/

Patient information

neuroblastoma patient information

Database